SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel coronavirus that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19). SARS-CoV-2 infection begins by attaching to angiotensin-converting enzyme 2 receptor (ACE2) via the spike glycoprotein, followed...
Saved in:
Main Authors: | Andrew R. McGill (Author), Roukiah Khalil (Author), Rinku Dutta (Author), Ryan Green (Author), Mark Howell (Author), Subhra Mohapatra (Author), Shyam S. Mohapatra (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SARS-CoV-2 vaccines-induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?
by: Rine Christopher Reuben, et al.
Published: (2021) -
ImmunoPhysics and ImmunoEngineering
Published: (2020) -
SARS-CoV-2 and the nervous system: review on pathogenesis of nervous system SARS-CoV-2 damage
by: Bai, Francesca
Published: (2021) -
Missed Opportunity Survey : Proxy Index For Community Participation
by: Tandon J, et al.
Published: (1993) -
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
by: G. Kanimozhi, et al.
Published: (2021)